<DOC>
	<DOCNO>NCT00077974</DOCNO>
	<brief_summary>To assess safety efficacy SU011248 patient metastatic , refractory renal cell carcinoma</brief_summary>
	<brief_title>A Pivotal Study Of SU011248 In The Treatment Of Patients With Cytokine-Refractory Metastatic Renal Cell Carcinoma .</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Renal Cell</mesh_term>
	<mesh_term>Sunitinib</mesh_term>
	<criteria>Cytokine refractory metastatic renal cell carcinoma clear cell component Radiographic evidence disease progression within 9 month completion 1 cytokine therapy Prior nephrectomy Prior treatment systemic therapy 1 cytokine therapy History know brain metastasis Uncontrolled hypertension significant cardiac event within 12 month prior study start</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2010</verification_date>
</DOC>